News
The U.S. Food and Drug Administration (FDA) has announced the official launch of Elsa, a cutting-edge generative Artificial ...
In a significant move, the U.S. Food and Drug Administration has provided De Novo authorisation Clairity Breast, the novel, ...
How artificial intelligence is being used to augment the work of experts treating patients with prostate cancer.
SMARTER SCREENINGS: The U.S. Food and Drug Administration (FDA) has approved the first artificial intelligence (AI) tool to predict breast cancer risk. 'WE WILL FIGHT': OpenAI CEO Sam Altman said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results